Through kinase assays, it has been shown that the D816V mutant can autoactivate 586-fold faster than native c-KIT [79], which explains the adverse prognostic impact of the c-kit mutation in this hot spot in patients with systemic mastocytosis [91]. The gene discussed is KIT; the disease is systemic mastocytosis.